Sartorius | SRT3 - Equity Capital And Reserves


Sartorius reported EUR2.93B in Equity Capital and Reserves for its fiscal quarter ending in September of 2026.





Equity Capital And Reserves Change Date
Akebia Therapeutics USD 20.37M 4.65M Sep/2026
Alaunos Therapeutics USD 652K 636K Jun/2026
Avita Medical AUD -27.84M 11.19M Jun/2026
Dianthus Therapeutics USD 1.24B 69.4M Sep/2026
Ionis Pharmaceuticals USD 439.74M 51.68M Jun/2026
IQVIA Holdings USD 6.66B 489M Sep/2026
Moderna USD 6.84B 76M Sep/2026
Organon & Co USD 1.19B 187M Sep/2026
Revvity USD 7.23B 46.02M Jun/2026
Sartorius EUR 2.93B 110.1M Sep/2026
Tectonic Therapeutic USD 223.85M 6.57M Jun/2026
Viatris USD 13.69B 574.9M Sep/2026
Xeris Pharmaceuticals USD 48.78M 58.52M Sep/2026